May 13 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 8.99 6.84 8.48
(+31.4 pct) (-7.7 pct) (-5.6 pct)
Operating 1.23 617 mln 609 mln
(+98.9 pct) (-8.3 pct) (-50.4 pct)
Recurring 1.20 592 mln 461 mln
(+102.2 pct) (+13.6 pct) (-61.5 pct)
Net
Net 654 mln 304 mln 268 mln
(+115.1 pct) (-45.3 pct) (-58.9 pct)
EPS 98.52 yen 46.22 yen 40.52 yen
EPS Diluted 98.47 yen 45.76 yen
Ann Div 8.00 yen NIL 8.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 8.00 yen NIL 8.00 yen
NOTE - Enbio Holdings, Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T